InspireMD, Inc. ( NSPR) - Key Metrics
NSPR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | -$0.19 | -$0.15 | -$0.15 |
| 2026Q1 | $0.05 | $0 | -$0.17 | -$0.17 |
| 2025Q4 | $0.04 | -$0.16 | -$0.13 | -$0.13 |
| 2025Q3 | $0.03 | -$0.17 | -$0.12 | -$0.12 |
| 2025Q2 | $0.03 | -$0.26 | -$0.16 | -$0.17 |
NSPR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.92 |
| 2026Q1 | 0% | 104.49 |
| 2025Q4 | 0% | -3.18 |
| 2025Q3 | 0% | -3.54 |
| 2025Q2 | 0% | -2.18 |
NSPR
Price: $0.79
52 week price:
Earnings Per Share: -0.61 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: Israel
Volume: 14200
Market Capitalization: 39.4 million